Over 18 years of age
prostate cancer, ENACT, Active surveillance, Enzalutamide, low grade prostate cancer
Either active surveillance of prostate cancer or treatment with Enzalutamide (160mg) taken by mouth once a day for one year.
Physical exams, various lab-work, digital rectal exams, analysis of urine, prostate biopsies, and questionnaires.
This study is open to male subjects, age 18 or older.
We invite you to take part in this research study because you have early stage (localized) prostate cancer that was diagnosed within the past six months.
You can only participate if you are currently undergoing active surveillance and no other treatment for your prostate cancer.